Consensus Avantor, Inc.

Stocks

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 00:00:03 29/08/2026 +04			5-day change	1st Jan Change
14.58 ^USD	-0.21%		+0.83%	+27.23%

08-28	Avantor, Inc. Announces Transition of Benoit Gourdier from Executive Vice President, Bioscience and Medtech Products, Effective October 14, 2026	CI
07-30	RBC Raises Price Target on Avantor to $14 From $9, Keeps Sector Perform Rating	MT

Evolution of the Average Target: Avantor, Inc.

Evolution of the Target Price: Avantor, Inc.

Changes in Analyst Recommendations: Avantor, Inc.

dc8cd2bc18aec250e96d.E78GeewKoMj4nIuUEC6Lls6UfLJBrZMhRpO7J25UecI.JdFECYF9w5221MasenfM7IXjF8ds59ViC-DYTD8cP51J_E0MrV3G-rXZ0g~1212d87a85feaa5dfcc4415864f96e81

Analysts' recommendations: Avantor, Inc.

07-30	RBC Raises Price Target on Avantor to $14 From $9, Keeps Sector Perform Rating	MT
07-30	Jefferies Upgrades Avantor to Hold From Underperform, Adjusts Price Target to $13 From $7	MT
07-30	Deutsche Bank Adjusts Avantor Price Target to $13 From $11, Maintains Hold Rating	MT
07-30	The Fed Gets a Better Inflation Number
07-30	Analysts recommendations: Humana, Lam Research, Procter & Gamble, Carvana, Fair Isaac…
07-29	(AVTR) Avantor Expects 2026 Adjusted EPS Range $0.80 to $0.83, vs. FactSet Est of $0.79	MT
07-13	BofA Securities Adjusts Avantor Price Target to $12 From $10	MT
05-15	Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says	MT
02-12	UBS Cuts Avantor Price Target to $10.50 From $13, Maintains Neutral Rating	MT
02-12	Deutsche Bank Cuts Price Target on Avantor to $9 From $12.50, Keeps Hold Rating	MT
12-17	Jefferies Downgrades Avantor to Underperform From Hold, Cuts Price Target to $9 From $12	MT
12-17	Analyst recommendations: Airbnb, Autozone, Constellation Brands, Fortinet, The Gap…
11-04	Raymond James Downgrades Avantor to Market Perform From Outperform	MT
11-04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
31/10/25	Avantor Shares Fall After JPMorgan, Barclays Downgrades	MT
30/10/25	JPMorgan Downgrades Avantor to Neutral From Overweight, Adjusts Price Target to $12 From $14	MT
30/10/25	Barclays Downgrades Avantor to Equalweight From Overweight, Adjusts Price Target to $12 From $15	MT
30/10/25	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…
20/10/25	BofA Adjusts Price Target on Avantor to $16.50 From $14	MT
03/09/25	RBC Cuts Price Target on Avantor to $16 From $17, Keeps Outperform Rating	MT
04/08/25	Deutsche Bank Trims Avantor Price Target to $14 From $15, Maintains Hold Rating	MT
04/08/25	RBC Cuts Price Target on Avantor to $17 From $20, Keeps Outperform Rating	MT
01/08/25	Jefferies Downgrades Avantor to Hold From Buy, $12 Price Target	MT
01/08/25	Lab supplies firm Avantor's Q2 sales down 1%	RE
29/04/25	Goldman Sachs Downgrades Avantor to Neutral From Buy, Adjusts Price Target to $14 From $23	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AVANTOR, INC.					-0.11%
	ABBOTT LABORATORIES					+6.87%
	MEDTRONIC PLC					+8.34%
	CENCORA, INC.					+14.68%
	BECTON, DICKINSON AND COMPANY					+3.24%
	HOYA CORPORATION					+25.66%
	DEXCOM, INC.					+3.63%
	MEDLINE INC.					+26.46%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.93%
	TERUMO CORPORATION					+23.4%
	Average					+13.21%
	Weighted average by Cap.					+11.13%